Auto Disable Syringes Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Allergan, Santen Pharmaceutical Co., Ltd., Bausch & Lomb, Alcon

The global Auto Disable Syringes market reached a value of US$ 18.95 Billion in 2021. Looking ahead, the market is expected to reach $ 45.67 billion by 2027, growing at a CAGR of 11.50% between 2022 and 2027.

Auto Disable Syringes Market Overview

Auto disable syringes are single-use syringes that are designed to prevent the barrel from descending again or to break the plunger after a single usage. These are a type of safety syringe designed to prevent syringe reuse. Advanced auto disable syringes offer extra features including needle stick prevention, which is accomplished by sliding a sheath or hood over the needle after each usage. Another mechanism requires retraction of the needle into the syringe barrel after each use, which can be manual or spring-loaded.

The primary driver of the global auto disable syringes market is the risk of infection and transfer of lethal diseases such as blood borne diseases, HIV, viral hepatitis, and others. According to the Centers for Disease Control and Prevention, drug use by injection is responsible for about one out of every ten new HIV diagnoses in the United States. HIV can persist for up to 42 days in an infected needle, depending on factors such as temperature, humidity, and other factors. The direct cost of needle stick injuries is estimated to be between $539 and $672 million per year by the Centers for Disease Control and Prevention, indicating that there is a significant unmet need for auto disable syringes.

The report aspects discussed the profile of the top manufacturers of the global Auto Disable Syringes market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Auto Disable Syringes Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.

Industry News and Updates:

Oct. 6, 2021: Boston Scientific completes $1.75B Baylis Medical acquisition--

Boston Scientific announced it had agreed to acquire the Canada-based company to expand its electrophysiology and structural heart product portfolios to include the radiofrequency (RF) NRG and VersaCross transseptal platforms, as well as a family of guidewires, sheaths and dilators used to support left heart access.

What are the major Applications, Types and Regions for Auto Disable Syringes Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Retractable
  
  
  
  • 
    

    Automatic Retractable

    
    
  
  
  • 
    

    Manually Retractable

    
    
  
  
  
  


• Non- Retractable
  
  
  
  • 
    

    Slip

    
    
  
  
  • 
    

    Lock

    
    
  
  
  • 
    

    Needle covers

    
    
  
  
  
  


• Others

By Application, it is segmented into

• Vaccines


• Infectious diseases


• Inflammatory/Auto-Immune Diseases


• Others

By End-User, it is segmented into

• Hospitals and clinics


• Ambulatory centers


• Others

Auto Disable Syringes Market Regional Analysis

North America is expected to dominate the market due to technical advancements, new product releases, and rapid adoption of blood collection and blood drawing technologies. Furthermore, the increased use of retractable syringes as a crucial safety measure, as well as the availability of these syringes with better performance, are expected to drive market expansion in the region. Furthermore, governmental approvals, an increase in the number of market competitors offering safety syringes, and a greater focus on safe injection techniques in hospitals and surgical centres are all driving market growth in the United States. The Asia Pacific auto disable syringes market, excluding Japan, is predicted to develop at the fastest CAGR due to increased healthcare spending. Because of their rising healthcare and per capita income, China and India are likely to account for the majority of market growth. The second largest market for auto disable syringes is predicted to be Europe, lead by Germany, France, and the United Kingdom. The gulf economies of Saudi Arabia, Kuwait, and Qatar are anticipated to dominate the worldwide auto disable syringes market in the Middle East and Africa. Because a major portion of the global market for auto disable syringes is captive, strong collaboration between players and organisations, including governments, is required, particularly in emerging nations.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Auto Disable Syringes Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Auto Disable Syringes Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Auto Disable Syringes Market report scope?

Frequently Asked Questions

What is the growth rate of Auto Disable Syringes Market?

The Auto Disable Syringes Market is growing at a CAGR of 5.80% over the next 5 years.

Who are the key players in Auto Disable Syringes Market?

BD (US), Iscon Surgicals Ltd. (India), AlShifa Medical Products Co. (Saudi Arabia), Hindustan Syringes & Medical Devices Ltd (US), Retractable Technologies, Inc. (US), Smiths Group plc (UK), Baxter (US), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic (Ireland), Hamilton Company (US), PharmaJet (US), VOGT MEDICAL (Germany), SANAVITA PHARMACEUTICALS GMBH (Germany), JMI Group (Bangladesh), AdvaCare Pharma. (India), ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., SWARG PHARMA (India), Nipro Medical Corporation (US), and Boston Scientific Corporation (US)

What are the significant types of Auto Disable Syringes Market?

Retractable, Non- Retractable, Others

What are the major end-use applications of Auto Disable Syringes Market?

Vaccines, Infectious diseases, Inflammatory/Auto-Immune Diseases, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.